NIH funds $12.5 million initiative to create the world's first integrated pancreas knowledgebase PanKbase (PanKbase teams include Dr. Anna Gloyn)

NIH funds $12.5 million initiative to create the world's first integrated pancreas knowledgebase PanKbase (PanKbase teams include Dr. Anna Gloyn)

Leading investigators in diabetes, pancreas and islet biology, and computational biology have received $12.5 million in two five-year awards from the National Institutes of Health (NIH) to create the world's first, integrated knowledgebase of human-derived tissue- and cellular-level pancreatic information to support innovative, collaborative and reproducible research.

Physicians perform first pancreatic islet transplantations at Stanford

Physicians perform first pancreatic islet transplantations at Stanford

Two patients received successful autologous islet transplants, a significant clinical milestone at Stanford, achieved by a talented team including SDRC members Walter Park MD, Marina Basina, MD, and Varia Kirchner, MD

Stanford Materials engineers including PI Dr. Eric Appel develop new drug delivery system could reduce daily diabetes shots to just three a year

Stanford Materials engineers including PI Dr. Eric Appel develop new drug delivery system could reduce daily diabetes shots to just three a year

Dietary management drugs have transformed Type 2 diabetes care, but daily injection routines are challenging for some patients. A new hydrogel could mean shots just three times a year.

A podcast about diabetes and genes - Dr. Anna Gloyn – the gene detective

A podcast about diabetes and genes - Dr. Anna Gloyn – the gene detective

The story of neonatal diabetes continues as we hear about the remarkable science that led  to  the genetic diagnosis and new treatment that transformed  Jack’s life in episode 1.  In this episode Maggie and Andrew talk to Anna Gloyn, the  scientist who discovered the gene that was usually altered when very young babies are  diagnosed with neonatal diabetes.

Drs. Addala, Chou, Gloyn, Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, & diabetes tech to advance health equity in diabetes diagnosis & management

Drs. Addala, Chou, Gloyn, Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, & diabetes tech to advance health equity in diabetes diagnosis & management

Drs. Ananta Addala, Danny Chou, Anna Gloyn and Rayhan Lal spoke to The SugarScience on flexing innovations in genetics, insulin bioengineering, and diabetes technology to advance health equity in diabetes diagnosis and management.

Why precision medicine leads to better diabetes care, a comprehensive report with contributions from Jessie Wong, SDRC Affinity leaders Anna Gloyn and Korey Hood, and SDRC member Jennifer Ikle

Why precision medicine leads to better diabetes care, a comprehensive report with contributions from Jessie Wong, SDRC Affinity leaders Anna Gloyn and Korey Hood, and SDRC member Jennifer Ikle

Diabetes can show up in almost anyone: pregnant women, babies, kids, teens, adults both young and old.

But the condition's various forms, all of which affect how the body processes blood sugar, can manifest quite differently in the hundreds of millions of people worldwide who have the disease -- making it perfect for the individualized approach known as precision medicine, Stanford Medicine researchers say.